HOME >> BIOLOGY >> NEWS
Irregular Heartbeat Shown To Increase Risk Of Death As Well As Disability;,,Particularly Harmful To Women

DALLAS, September 8-- Atrial fibrillation -- a condition in which the heart beats irregularly -- significantly increases the risk of dying, particularly for women, report scientists in today's Circulation: Journal of the American Heart Association.

According to the study, men with atrial fibrillation (AF) had a risk of death 1.5 times greater than men without AF. For women, the risk of death was 1.9 times greater in women with AF when compared to women without AF.

Prior research has shown that the condition results in more disability, but in this study researchers looked specifically at death rates and found people with atrial fibrillation had an increased risk of death.

"Women tend to live longer than men," says the study's lead author Emelia J. Benjamin, M.D., associate professor of medicine at Boston University School of Medicine and director of echocardiology for the Framingham Heart Study. "However, in our study, the risk of dying for women with atrial fibrillation at any given age looked similar to men of the same age who had atrial fibrillation."

In the study, the risk for men is heavily influenced by death in the first 30 days after diagnosis, while the increased risk of death for women continues throughout life, says Benjamin. The odds that a woman with AF would die prematurely were actually higher than those for men with the disorder, eliminating the survival advantage that women generally have over men.

AF is caused by a disruption in the rhythm of the atria, the heart's upper two chambers. It causes an irregular heartbeat that results in the heart pumping blood less effectively. About 2 million Americans have AF, according to an editorial in Circulation: Journal of the American Heart Association by J. Thomas Bigger Jr., M.D., professor of medicine and of pharmacology at Columbia University in New York City.

As the Baby Boom generation ages, AF and the sickness and deaths it causes will i
'"/>

Contact: Brian Henry
brianh@heart.org
(214) 706-1135
American Heart Association
7-Sep-1998


Page: 1 2 3

Related biology news :

1. Body Building: Tissue Engineered Organs A Heartbeat Away
2. New Drug Shown Effective Against Vancomycin-Resistant Bacteria
3. High Temperature Immediately Following A Stroke Leads To Worse Outcome; Quick Cooling Shown To Have Benefit
4. Binding Proteins Shown To Play Key Role In Early Brain Development
5. Arsenic Shown To Induce Cancer Remission
6. Three-Way Gene-Gene-Environmental Exposure Interaction Shown By NIEHS To Escalate Smoking-Related Bladder Cancer
7. Early Restoration Of Blood Flow Following A Heart Attack Shown To Improve Long-Term Survival For Patients
8. Growth Factors Shown To Increase Vitamin C In The Immune System
9. Increased atmospheric carbon dioxide promotes algal growth
10. Increased temperature may prevent winter flounder from rebounding in east coast estuaries
11. Get your blood moving: Increased blood flow could lead to healthier blood vessels

Post Your Comments:
(Date:5/21/2013)... of Michigan Water Center today awarded 12 research ... restoration and protection efforts. , The two-year grants ... including efforts to track the remediation of harmful ... control non-native weedy plant invasions; study chromosomal damage ... to restoration activities. , The grants were awarded ...
(Date:5/21/2013)... The American Chemical Society (ACS), the world,s largest ... 246th National Meeting & Exposition, September 8-12, 2013, ... the Indiana Convention Center and at area hotels. ... discoveries that span science,s horizons from astronomy ... broadcast and online journalists a rich assortment of ...
(Date:5/21/2013)... , May 21, 2013 Royal Philips Electronics ... the world,s first portable ultrasound with Philips, industry leading ... capability. The CX50 xMATRIX with available Live 3D TEE ... at the EuroPCR, official meeting for the ... Since its launch in 2012, Philips CX50 ...
Breaking Biology News(10 mins):U-M Water Center awards $570K in Great Lakes restoration grants 2U-M Water Center awards $570K in Great Lakes restoration grants 3U-M Water Center awards $570K in Great Lakes restoration grants 4Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system 2
(Date:5/21/2013)... Clinverse, Inc. , a ... trials, announced today it has formed a strategic ... ClinPay® FLS eClinical commerce platform aggregates data collected ... SpendMD ™, Aggregate Spend Solutions’ recently-launched flagship product, ... reporting transfer of value at investigator meetings or ...
(Date:5/21/2013)... As the R&D sector becomes ... the industry to deliver better products, faster. Collaborations ... companies often means turning big ideas into reality, ... collaboration with Sensidose AB and Recipharm, is one ... to market sooner. The partnership resulted in the ...
(Date:5/21/2013)... ROCKVILLE, Md. , May 21, 2013 /PRNewswire/ ... "Phase 1 study of margetuximab (MGAH22), an Fc-modified ... solid tumors expressing the HER2 oncoprotein," will be ... American Society of Clinical Oncology during the Developmental ... June 3 at 4:15 – 4:30 PM.  The ...
(Date:5/21/2013)... Bed bugs have become so widespread in the past ... to chemical-based pesticides for help to completely get rid of ... solutions present, the company advised the public to kill ... According to My Cleaning Products, chemical-based pesticides are not as ... shared that the pests have already developed immunity to the ...
Breaking Biology Technology:Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 2New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 3
Cached News: